Literature DB >> 22514339

Extensive mutagenesis of the conserved box E motif in duck hepatitis B virus P protein reveals multiple functions in replication and a common structure with the primer grip in HIV-1 reverse transcriptase.

Yong-Xiang Wang1, Cheng Luo, Dan Zhao, Jürgen Beck, Michael Nassal.   

Abstract

Hepadnaviruses, including the pathogenic hepatitis B virus (HBV), replicate their small DNA genomes through protein-primed reverse transcription, mediated by the terminal protein (TP) domain in their P proteins and an RNA stem-loop, ε, on the pregenomic RNA (pgRNA). No direct structural data are available for P proteins, but their reverse transcriptase (RT) domains contain motifs that are conserved in all RTs (box A to box G), implying a similar architecture; however, experimental support for this notion is limited. Exploiting assays available for duck HBV (DHBV) but not the HBV P protein, we assessed the functional consequences of numerous mutations in box E, which forms the DNA primer grip in human immunodeficiency virus type 1 (HIV-1) RT. This substructure coordinates primer 3'-end positioning and RT subdomain movements during the polymerization cycle and is a prime target for nonnucleosidic RT inhibitors (NNRTIs) of HIV-1 RT. Box E was indeed critical for DHBV replication, with the mutations affecting the folding, ε RNA interactions, and polymerase activity of the P protein in a position- and amino acid side chain-dependent fashion similar to that of HIV-1 RT. Structural similarity to HIV-1 RT was underlined by molecular modeling and was confirmed by the replication activity of chimeric P proteins carrying box E, or even box C to box E, from HIV-1 RT. Hence, box E in the DHBV P protein and likely the HBV P protein forms a primer grip-like structure that may provide a new target for anti-HBV NNRTIs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22514339      PMCID: PMC3393573          DOI: 10.1128/JVI.00011-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  A small 2'-OH- and base-dependent recognition element downstream of the initiation site in the RNA encapsidation signal is essential for hepatitis B virus replication initiation.

Authors:  S G Schaaf; J Beck; M Nassal
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

2.  The majority of duck hepatitis B virus reverse transcriptase in cells is nonencapsidated and is bound to a cytoplasmic structure.

Authors:  E Yao; Y Gong; N Chen; J E Tavis
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Specific targeting highly conserved residues in the HIV-1 reverse transcriptase primer grip region. Design, synthesis, and biological evaluation of novel, potent, and broad spectrum NNRTIs with antiviral activity.

Authors:  Caterina Fattorusso; Sandra Gemma; Stefania Butini; Paul Huleatt; Bruno Catalanotti; Marco Persico; Meri De Angelis; Isabella Fiorini; Vito Nacci; Anna Ramunno; Manuela Rodriquez; Giovanni Greco; Ettore Novellino; Alberto Bergamini; Stefano Marini; Massimo Coletta; Giovanni Maga; Silvio Spadari; Giuseppe Campiani
Journal:  J Med Chem       Date:  2005-11-17       Impact factor: 7.446

4.  Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC).

Authors:  K Das; X Xiong; H Yang; C E Westland; C S Gibbs; S G Sarafianos; E Arnold
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

5.  Alterations to the primer grip of p66 HIV-1 reverse transcriptase and their consequences for template-primer utilization.

Authors:  M Ghosh; P S Jacques; D W Rodgers; M Ottman; J L Darlix; S F Le Grice
Journal:  Biochemistry       Date:  1996-07-02       Impact factor: 3.162

6.  Efficient Hsp90-independent in vitro activation by Hsc70 and Hsp40 of duck hepatitis B virus reverse transcriptase, an assumed Hsp90 client protein.

Authors:  Jürgen Beck; Michael Nassal
Journal:  J Biol Chem       Date:  2003-07-08       Impact factor: 5.157

7.  Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance.

Authors:  H Huang; R Chopra; G L Verdine; S C Harrison
Journal:  Science       Date:  1998-11-27       Impact factor: 47.728

8.  Hepatitis B virus reverse transcriptase and epsilon RNA sequences required for specific interaction in vitro.

Authors:  Jianming Hu; Morgan Boyer
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

Review 9.  Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance.

Authors:  C Tantillo; J Ding; A Jacobo-Molina; R G Nanni; P L Boyer; S H Hughes; R Pauwels; K Andries; P A Janssen; E Arnold
Journal:  J Mol Biol       Date:  1994-10-28       Impact factor: 5.469

10.  Mechanistic characterization and molecular modeling of hepatitis B virus polymerase resistance to entecavir.

Authors:  Ann W Walsh; David R Langley; Richard J Colonno; Daniel J Tenney
Journal:  PLoS One       Date:  2010-02-12       Impact factor: 3.240

View more
  9 in total

1.  Non-nucleoside hepatitis B virus polymerase inhibitors identified by an in vitro polymerase elongation assay.

Authors:  Shogo Nakajima; Koichi Watashi; Kento Fukano; Senko Tsukuda; Kousho Wakae; Hideki Aizaki; Masamichi Muramatsu; Takaji Wakita; Tetsuya Toyoda
Journal:  J Gastroenterol       Date:  2019-11-25       Impact factor: 7.527

2.  Hepatitis B virus molecular biology and pathogenesis.

Authors:  R Jason Lamontagne; Sumedha Bagga; Michael J Bouchard
Journal:  Hepatoma Res       Date:  2016-07-01

3.  Unveiling the roles of HBV polymerase for new antiviral strategies.

Authors:  Daniel N Clark; Jianming Hu
Journal:  Future Virol       Date:  2015       Impact factor: 1.831

Review 4.  Close encounters: Moving along bumps, breaks, and bubbles on expanded trinucleotide tracts.

Authors:  Aris A Polyzos; Cynthia T McMurray
Journal:  DNA Repair (Amst)       Date:  2017-06-09

5.  Carbonyl J acid derivatives block protein priming of hepadnaviral P protein and DNA-dependent DNA synthesis activity of hepadnaviral nucleocapsids.

Authors:  Yong-Xiang Wang; Yu-Mei Wen; Michael Nassal
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

6.  Stable Human Hepatoma Cell Lines for Efficient Regulated Expression of Nucleoside/Nucleotide Analog Resistant and Vaccine Escape Hepatitis B Virus Variants and Woolly Monkey Hepatitis B Virus.

Authors:  Xin Cheng; Weiwei Guan; Shuo Sun; Baosheng Li; Haijun Li; Fubiao Kang; Jiwen Kang; Dongliang Yang; Michael Nassal; Dianxing Sun
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

Review 7.  Hepatitis B virus reverse transcriptase: diverse functions as classical and emerging targets for antiviral intervention.

Authors:  Scott A Jones; Jianming Hu
Journal:  Emerg Microbes Infect       Date:  2013-09-04       Impact factor: 7.163

8.  Structure of the HIV-1 reverse transcriptase Q151M mutant: insights into the inhibitor resistance of HIV-1 reverse transcriptase and the structure of the nucleotide-binding pocket of Hepatitis B virus polymerase.

Authors:  Akiyoshi Nakamura; Noriko Tamura; Yoshiaki Yasutake
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-10-23       Impact factor: 1.056

9.  Screening and Evaluation of Novel Compounds against Hepatitis B Virus Polymerase Using Highly Purified Reverse Transcriptase Domain.

Authors:  Eriko Ohsaki; Keiji Ueda
Journal:  Viruses       Date:  2020-07-31       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.